SNP recommendation guidelines: Difference between revisions

PRI
No edit summary
(PRI)
 
Line 164: Line 164:
* Availability hinges on authorised prescriber, special access, or personal importation scheme.
* Availability hinges on authorised prescriber, special access, or personal importation scheme.
* TGA has a [https://www.tga.gov.au/resources/resource/guidance/authorised-prescribers-unapproved-nicotine-vaping-products list of authorised prescribers] (GPs).
* TGA has a [https://www.tga.gov.au/resources/resource/guidance/authorised-prescribers-unapproved-nicotine-vaping-products list of authorised prescribers] (GPs).
|}
== US ==
=== PRI: Position on Vaping / Harm Reduction ===
{| class="wikitable"
|+
!
!
|-
|Link
|https://www.physiciansresearchinstitute.org/harm-reduction/
|-
|Audience
|GPs
|-
|By
|Physicians Research Institute
|-
|Considerations
|
* Today’s cigarattes are more difficult to quit. Standard treatment has a noticeable failure rate.
* Physicians misperceive the relative risks of nicotine in comparison to combustion.
* NVPs are a legal alternative, 20 times less harmful than continued smoking.
* Switching measurably reduces harm, and might even help even those not intending to quit.
|}
|}
Administrators, Administrators, translator
59

edits